PharmaCorp Rx Inc. Reports First Quarter 2025 Results and Announces Non-Binding Letters of Intent to Acquire Four Pharmacies

SASKATOON, Saskatchewan, May 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the filing on SEDAR+ of its unaudited financial statements together with associated MD&A for the first quarter ending March 31, 2025 as well as the execution of non-binding letters of intent to acquire four pharmacies. Q1 2025 Financial and Operational HighlightsPharmaCorp Rx Inc. is pleased to report net income of $254,000 for the first quarter ending March 31 ...